A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen Responsiveness

A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen Responsiveness

Most women diagnosed with breast cancer (BC) have estrogen receptor alpha-positive (ER+) disease. The current mouse models of ER+ BC often rely on exogenous estrogen to encourage metastasis, which modifies the immune system and the function of some tissues like bone. Other studies use genetically mo...

Full description

Bibliographic Details
Main Authors:	Kendall L. Langsten, Lihong Shi, Adam S. Wilson, Salvatore Lumia, Brian Westwood, Alexandra M. Skeen, Maria T. Xie, Victoria E. Surratt, JoLyn Turner, Carl D. Langefeld, Ravi Singh, Katherine L. Cook, Bethany A. Kerr
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	Cancers
Subjects:	estrogen receptor alpha metastasis bone metastasis antiestrogen treatment
Online Access:	https://www.mdpi.com/2072-6694/15/24/5773

Similar Items

Effects of estrogens and antiestrogens on gonadal sex differentiation and embryonic development in the domestic fowl (Gallus gallus domesticus)
by: Luzie Jessl, et al.
Published: (2018-07-01)

Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells
by: Nicholas Pulliam, et al.
Published: (2019-01-01)

Advances in Association of Estrogen and Human Non-small Cell Lung Cancer
by: Juan HE, et al.
Published: (2015-05-01)

Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers
by: Aurélien Linares, et al.
Published: (2019-07-01)

G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells
by: Andrea K. Corbet, et al.
Published: (2023-07-01)

Insights Into the Role of Epigenetic Factors Determining the Estrogen Response in Estrogen-Positive Ovarian Cancer and Prospects of Combining Epi-Drugs With Endocrine Therapy
by: Sadia Sarwar, et al.
Published: (2022-07-01)

Antiestrogenic Activity and Possible Mode of Action of Certain New Nonsteroidal Coumarin-4-acetamides
by: Maha S. Almutairi, et al.
Published: (2020-03-01)

A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer
by: Adisorn Ratanaphan
Published: (2012-11-01)

Protein Aggregation Patterns Inform about Breast Cancer Response to Antiestrogens and Reveal the RNA Ligase RTCB as Mediator of Acquired Tamoxifen Resistance
by: Inês Direito, et al.
Published: (2021-06-01)

HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer
by: Xiaodan Sun, et al.
Published: (2022-10-01)

Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones
by: Priscila López-Rojas, et al.
Published: (2022-05-01)

Aurora A and Mcl-1: new potential treatment targets in antiestrogen-resistant breast cancer
by: Christina W. Yde
Published: (2021-11-01)

Incident Type 2 Diabetes Risk of Selective Estrogen Receptor Modulators in Female Patients with Breast Cancer
by: Yeo-Jin Choi, et al.
Published: (2021-09-01)

Abrogating endocrine resistance by targeting ER alpha and PI3K in breast cancer
by: Emily M Fox, et al.
Published: (2012-10-01)

A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
by: Léa Clusan, et al.
Published: (2021-01-01)

Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
by: Erika Di Zazzo, et al.
Published: (2019-09-01)

Differential MicroRNA Landscape Triggered by Estrogens in Cancer Associated Fibroblasts (CAFs) of Primary and Metastatic Breast Tumors
by: Adele Vivacqua, et al.
Published: (2019-03-01)

4,4′-(9-Fluorenylidene)dianiline (BAFL) is antiestrogenic and has adverse effects on female development in CD-1 mice
by: Xiaojing Jia, et al.
Published: (2022-11-01)

Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells
by: David J Hosfield, et al.
Published: (2022-05-01)

The Role of Estrogen Receptors in Cardiovascular Disease
by: Laila Aryan, et al.
Published: (2020-06-01)

Rosetta Stone for Cancer Cure: Comparison of the Anticancer Capacity of Endogenous Estrogens, Synthetic Estrogens and Antiestrogens
by: Zsuzsanna Suba
Published: (2023-04-01)

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial
by: Suhail Ahmad Mir, et al.
Published: (2022-10-01)

The Relationship between Time, Race, and Estrogen Receptor Alpha in Estradiol-Induced Dermal Fibrosis
by: DeAnna Baker Frost, et al.
Published: (2024-01-01)

Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells
by: Carina Forsare, et al.
Published: (2020-04-01)

High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin
by: Natasa Bajalovic, et al.
Published: (2022-08-01)

Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition
by: Robert B. Wilson, et al.
Published: (2020-06-01)

Role of estrogen receptors in health and disease
by: Peng Chen, et al.
Published: (2022-08-01)

Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers
by: Amira F. Mahdi, et al.
Published: (2020-06-01)

Silver Nanoparticles Modulate the Epithelial-to-Mesenchymal Transition in Estrogen-Dependent Breast Cancer Cells In Vitro
by: Michał Rakowski, et al.
Published: (2021-08-01)

Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
by: Erin R. Scheidemann, et al.
Published: (2021-11-01)

Discovery of Highly Functionalized 5-hydroxy-2<i>H</i>-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen
by: Miguel Guerra-Rodríguez, et al.
Published: (2022-10-01)

Plasma Sphingosine-1-Phosphate Levels Are Associated with Progression of Estrogen Receptor-Positive Breast Cancer
by: Mayuko Ikarashi, et al.
Published: (2021-12-01)

Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management
by: Viola Melone, et al.
Published: (2023-01-01)

MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer
by: Begoña Alday-Parejo, et al.
Published: (2020-01-01)

SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models
by: Feng Zhou, et al.
Published: (2023-08-01)

Roles of Estrogen, Estrogen Receptors, and Estrogen-Related Receptors in Skeletal Muscle: Regulation of Mitochondrial Function
by: Kenta Yoh, et al.
Published: (2023-01-01)

Mastopathy Myths and Reality: Good Choice for Pharm Industry?
by: Gulbarshin Darisheva, et al.
Published: (2018-09-01)

Divergent Effects of Daidzein and Its Metabolites on Estrogen-Induced Survival of Breast Cancer Cells
by: Emiliano Montalesi, et al.
Published: (2020-01-01)

Estrogen Signaling in Bone
by: Nuria Lara-Castillo
Published: (2021-05-01)

A histopathological study on breast carcinoma with special reference to cyclin-D1 and estrogen receptor
by: Payel Hazari, et al.
Published: (2024-03-01)